Azedra

Proxy adviser backs ouster of Progenics CEO in activist battle

An activist investor is angling to oust Progenics' CEO and put three nominees on the drugmaker's board. Backing from a major proxy adviser helps.

Kyle Blankenship Oct 28, 2019 10:40am

Progenics buys a manufacturing facility for radiotherapeutic

Feb 12, 2019 10:24am

Progenics snags FDA nod for $300K Azedra

Jul 31, 2018 10:15am